{"id":16416,"date":"2021-05-06T18:24:05","date_gmt":"2021-05-06T16:24:05","guid":{"rendered":"https:\/\/www.cirff.it\/?p=16416"},"modified":"2024-01-12T12:24:17","modified_gmt":"2024-01-12T11:24:17","slug":"multimorbidity-and-polypharmacy-2","status":"publish","type":"post","link":"https:\/\/www.cirff.it\/?p=16416&lang=en","title":{"rendered":"Multimorbidity and polypharmacy"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"16416\" class=\"elementor elementor-16416\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5e9f3800 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5e9f3800\" data-element_type=\"section\" data-settings=\"{&quot;ekit_has_onepagescroll_dot&quot;:&quot;yes&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4e2aa659\" data-id=\"4e2aa659\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2a969a61 elementor-widget elementor-widget-text-editor\" data-id=\"2a969a61\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\"><!-- wp:paragraph -->\n<p><strong>CIRFF<\/strong> and the <strong>Epichron Research Group of the Aragon Health Search Institute (IIS Aragon) in Zaragoza <\/strong>have been collaborating since 2013 to study the complexity and evolution of <strong>multimorbidity<\/strong> and <strong>polypharmacy<\/strong> models from <strong>real-world data<\/strong>, comparing results emerging from different European settings.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} -->\n<p style=\"font-size: 15px;\"><strong>Available results:<\/strong><\/p>\n<!-- \/wp:paragraph -->\n\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} -->\n<ul>\n<li style=\"font-size: 15px;\"><a href=\"https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0210701\"><strong>Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.<\/strong> <em>Plosone<\/em><\/a><br \/><br \/><!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} --><\/li>\n<li style=\"font-size: 15px;\"><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.586187\/full\"><strong>Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients.<\/strong> <em>Frontiers in Pharmacology<br \/><br \/><\/em><\/a><!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} --><\/li>\n<li style=\"font-size: 15px;\"><a href=\"https:\/\/www.mdpi.com\/1660-4601\/17\/10\/3742\"><strong>Initial Therapy, Regimen Change, and Persistence in a Spanish Cohort of Newly Treated Type 2 Diabetes Patients: A Retrospective, Observational Study Using Real-World Data.<\/strong> <em>International Journal of Environmental Research and Public Health<\/em><\/a><br \/><br \/><!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} --><\/li>\n<li style=\"font-size: 15px;\"><a href=\"https:\/\/www.elsevier.es\/es-revista-medicina-clinica-2-linkresolver-adherencia-al-tratamiento-hipertension-arterial-S0025775318306547\"><strong>Adherencia al tratamiento de hipertensi\u00f3n arterial, hipercolesterolemia y diabetes en poblaci\u00f3n anciana de una cohorte espa\u00f1ola.<\/strong><em> Medicina Cl\u00ednica<\/em><\/a><br \/><br \/><!-- \/wp:paragraph -->\n\n<!-- wp:paragraph {\"style\":{\"typography\":{\"fontSize\":15}}} --><\/li>\n<li style=\"font-size: 15px;\"><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2019.00870\/full\"><strong>Treatment Patterns of Diabetes in Italy: A Population-Based Study.<\/strong><em> Frontiers in Pharmacology<\/em><\/a><\/li>\n<\/ul>\n<!-- \/wp:paragraph --><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>CIRFF and the Epichron Research Group of the Aragon Health Search Institute (IIS Aragon) in Zaragoza have been collaborating since 2013 to study the complexity and evolution of multimorbidity and polypharmacy models from real-world data, comparing results emerging from different European settings. Available results: Patterns of multimorbidity and polypharmacy in young and adult population: Systematic [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[72],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v15.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Multimorbidity and polypharmacy - CIRFF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cirff.it\/?p=16416&#038;lang=en\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Multimorbidity and polypharmacy - CIRFF\" \/>\n<meta property=\"og:description\" content=\"CIRFF and the Epichron Research Group of the Aragon Health Search Institute (IIS Aragon) in Zaragoza have been collaborating since 2013 to study the complexity and evolution of multimorbidity and polypharmacy models from real-world data, comparing results emerging from different European settings. Available results: Patterns of multimorbidity and polypharmacy in young and adult population: Systematic [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cirff.it\/?p=16416&amp;lang=en\" \/>\n<meta property=\"og:site_name\" content=\"CIRFF\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-06T16:24:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-12T11:24:17+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\">\n\t<meta name=\"twitter:data1\" content=\"1 minuto\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cirff.it\/#website\",\"url\":\"https:\/\/www.cirff.it\/\",\"name\":\"CIRFF\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.cirff.it\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/?p=16416&lang=en#webpage\",\"url\":\"https:\/\/www.cirff.it\/?p=16416&lang=en\",\"name\":\"Multimorbidity and polypharmacy - CIRFF\",\"isPartOf\":{\"@id\":\"https:\/\/www.cirff.it\/#website\"},\"datePublished\":\"2021-05-06T16:24:05+00:00\",\"dateModified\":\"2024-01-12T11:24:17+00:00\",\"author\":{\"@id\":\"https:\/\/www.cirff.it\/#\/schema\/person\/7c3f5b41687409b5766f80d4764f45ec\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cirff.it\/?p=16416&lang=en#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cirff.it\/?p=16416&lang=en\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cirff.it\/?p=16416&lang=en#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/\",\"url\":\"https:\/\/www.cirff.it\/\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/?p=16416&lang=en\",\"url\":\"https:\/\/www.cirff.it\/?p=16416&lang=en\",\"name\":\"Multimorbidity and polypharmacy\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cirff.it\/#\/schema\/person\/7c3f5b41687409b5766f80d4764f45ec\",\"name\":\"cirff-admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.cirff.it\/#personlogo\",\"inLanguage\":\"it-IT\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa8cd28d2ef4614914235b9063d71805?s=96&d=mm&r=g\",\"caption\":\"cirff-admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/posts\/16416"}],"collection":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16416"}],"version-history":[{"count":6,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/posts\/16416\/revisions"}],"predecessor-version":[{"id":18141,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/posts\/16416\/revisions\/18141"}],"wp:attachment":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}